Loading...
Specialists 2017-10-10T15:32:39+00:00

Meet some of our doctors

Steven E. Come, MD

Former Director, Breast Cancer Program, Beth Israel Deaconess Medical Center Institute Physician
Beth Israel Deaconess Medical Center Associate Professor
Harvard Medical School Member
Breast Cancer Program, Beth Israel Deaconess Medical Center

Dr. Steven Come received his MD from Harvard Medical School in 1972. He completed a residency training at Beth Israel Deaconess Medical Center, followed by a fellowship in oncology at the National Cancer Institute. He later joined Beth Isarel Deaconess Medical Center as a medical oncologist, specializing in breast cancer, where he served as the Director of the Breast Cancer Program.

Dr. Come was the former Director at BIDMC Breast Cancer Program, and has been a medical oncologist and breast cancer specialist at BIDMC for 45 years. His research interests include optimal strategies to combine chemotherapy and breast radiation to manage early breast cancer, as well as ways to better define prognostic factors in primary breast cancer.

Dr. Come is a member of the American Society of Clinical Oncology (ASCO). He has been recognized by Caste Connolly as one of “America’s Top Doctors”2002-2014 and by Boston Magazine 2008-2013.

Christopher Azzoli, G., MD

Former Chair, American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Committee
Institute Physician, Thoracic Oncology Program, Massachusetts General Hospital

Dr. Christopher G. Azzoli received his MD from Johns Hopkins University School of Medicine and completed his residency at John Hopkins Hospital. He then went on to complete a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York. He served as faculty at MSKCC from 2002-2012 and currently serves as faculty at the Massachusetts General Hospital (MGH) Cancer Center, with an academic appointment at the Harvard Medical School. Dr. Azzoli joined Massachusetts General Hospital’s Thoracic Oncology Program in 2012.

Since 2003, Dr. Azzoli has authored, or co-authored clinical practice guidelines from the American Society of Clinical Oncology (ASCO) for the care of patients with early-stage, and metastatic lung cancer. Dr. Azzoli served as Chairman of the ASCO Clinical Practice Guideline Committee from 2012-2013.

Throughout his career Dr. Azzoli has focused primarily on the development of new drug treatments for patients with lung cancer. He currently serves the MGH community as a senior clinician, spending most of his time caring for patients with lung cancer, thymoma, mesothelioma, and esophageal cancer.  He is a co-investigator on over 40 new drug trials for lung cancer, with special interest now in Immuno-Oncology.

Francis James McGovern, MD

Director, Urologic Trauma, Massachusetts General Hospital
Surgeon, Massachusetts General Hospital
Assistant Professor of Surgery, Harvard Medical School

Dr. Francis J. McGovern graduated from Case Western Reserve School of Medicine. He completed his residency in Surgery at Massachusetts General Hospital (MGH) in 1985 and an additional residency in Urology at Massachusetts General Hospital in 1988. Dr. McGovern now serves are the Director of Urologic Trauma at MGH. He specializes in the treatment of urological cancer and related research.

He has served as faculty at MGH since 1989 and is currently an Assistant Clinical Professor in Surgery at Harvard Medical School. In 2006 and 2009, he received the Partners in Excellence Award from Partners Health Care. Most recently, he was recognized for his work in urologic surgery with The Brian A. McGovern, MD, Awards for Clinical Excellence and by The One Hundred campaign, which recognizes care providers who are changing how we fight cancer. He has been recognized as an American Cancer Society Fellow and Checkbook Top Doc. Dr. McGovern has performed more than 3,000 surgeries involving the treatment of prostate cancer. He is also involved in numerous clinical trials for adiofrequency ablation of renal cell carcinoma.

Dr. Inga Lennes, MPH, MBA

Senior VP, Service Excellence and Practice Improvement Division Massachusetts General Hospital (MGH) Cancer Center
Director of Survivorship Program MGH Cancer Center
Director of Pulmonary Nodule Clinic, MGH Cancer Center
Instructor of Medicine Harvard Medical School

Dr. Lennes received her MD from the University of Massachusetts Medical School. She completed her internal medicine residency training and served as Chief Medical Resident at Beth Israel Deaconess Medical Center.  She trained as a Hematology and Oncology Fellow in the Dana Farber/Partners Cancer Care Fellowship.

Dr. Lennes is a medical oncologist in the Center for Thoracic Cancers and specializes in seeing all lung cancers and esophageal cancer. She is the founder and director of the Pulmonary Nodule Clinic at Massachusetts General Hospital and works closely with colleagues to study and implement lung cancer screening and improve nodule management.  Dr. Lennes is the Massachusetts General Physicians Organization Senior Vice President for Service Excellence and Practice Improvement.

Don S. Dizon, MD

Director of Medical Oncology, Rhode Island Hospital
Head of Women’s Cancers Lifespan Cancer Institute 
Former Clinical Co-Director of Gynecologic Oncology Massachusetts General Hospital
Former Director of The Oncology Sexual Health Clinic Massachusetts General Hospital
Former Instructor of Medicine, Massachusetts General Hospital

Dr. Dizon received his MD from University of Rochester School of Medicine and Dentistry. He completed residency training at Yale-New Haven Hospital while serving aa the clinical educator for the Primary Care Program at the Yale University School of Medicine. Dr. Dizon later completed a fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center (MSKCC). He then joined the Developmental Therapeutics service at MSKCC where he served as a member of the Gynecologic Oncology Disease Management Team.

Dr. Dizon joined Massachusetts General Hospital where he served as the Co-Director of Gynecologic Oncology, founded and served as Director of The Oncology Sexual Health Clinic, and was also an Instructor of Medicine, Massachusetts General Hospital. As of September 1, 2017, Dr. Dizon will join Rhode Island Hospital as the Director of Medical Oncology and the Head of Women’s Cancers at the Lifespan Cancer Institute. He will also be an Associate Professor of Medicine The Warren Alpert Medical School of Brown University.

Dr. Dizon remains committed to clinical research in novel treatments for women with gynecologic cancers, cancer survivorship, and sexual health.

Jeffrey A. Meyerhardt, MD, MPH

Clinical Director, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute
Deputy Clinical Research Officer, Dana Farber Cancer Institute
Attending Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School

Dr. Meyerhardt received his MD from Yale University School of Medicine in 1997. He completed a residency in internal medicine at Beth Israel Deaconness Medical Center, in Boston and then trained as a Hematology and Oncology Fellow in the Dana Farber/Partners Cancer Care Fellowship.

In 2002, Dr. Meyerhardt was named the Irving Jancock Fellow. He joined the Gastointestinal Cancer Center at Dana Farber Cancer Institute in 2002. In 2004, he was awarded the Tisch Outstanding Achievement Award and also became an associate professor of medicine at Harvard Medical School.

Dr. Meyerhardt currently serves as an attending oncologist at Dana Farber Cancer Institute. He is the Clinical Director of the Gastrointestinal Cancer Center and the Deputy Clinical Research Officer. Dr. Meyerhardt is appointed faculty at Harvard Medical School as an Associate Professor of Medicine.

Eric P. Winer, MD

Chief Clinical Strategy Officer, Dana Farber Cancer Institute
Chief, Division of Women’s Cancers, Dana Farber Cancer Institute
Director, Breast Oncology Center, Susan F. Smith Center for Women’s Cancers, Dana Farber Cancer Institute
Thompson Chair, Breast Cancer Research, Dana Farber Cancer Institute
Professor of Medicine, Harvard Medical School

Dr. Winer received his MD from Yale University in 1983. He completed residency training in internal medicine and served as chief resident at Yale-New Haven Hospital. He then completed a fellowship in hematology-oncology at Duke University Medical Center. From 1989 to 1997, Dr. Winer served on the Duke faculty, where he became co-director of the Multidisciplinary Breast Program. In 1997, he joined Dana-Farber Cancer Institute, where he is Chief Strategy Officer, Chief of the Division of Women’s Cancers, and Director of the Breast Oncology Center. Dr. Winer also serves as the Thompson Chair for Breast Cancer Research at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School.

Dr. Winer has been bestowed many awards throughout his career. Some of the more prestigious include the Gianni Bonadonna Breast Cancer Award and Lecture from the American Society of Clinical Oncology in 2017, The William L. McGuire Memorial Lectureship from the San Antonio Breast Cancer Symposium in 2016, and the Advancing the Careers of Women Faculty Award from Dana-Farber Cancer Institute in 2013. Dr. Winer also received the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School in 2009, the Tisch Award for Outstanding Achievement from Dana-Farber Cancer Institute in 2006, the Claire W. and Richard P. Morse Research Award in 2002, and the Joseph Sokal Memorial Lecturer from Duke University in 1999.

David P. Steensma, MD

Attending Physician, Hematologic Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute
Attending Physician, Hematological Malignancies Service, Brigham And Women’s Hospital
Associate Professor of Medicine, Harvard Medical School
Voting Member, Oncology Drug Advisory Committee (ODAC), FDA

Dr. Steensma received his MD from the University of Chicago Pritzker School of Medicine in 1996. He completed his residency in internal medicine followed by a combined fellowship in hematology/oncology at the Mayo Clinic. Following the completion of formal training, Dr. Steensma spent time as a visiting research scholar in the Molecular Hematology Unit of the Weatherall Institute of Molecular Medicine in Oxford, UK where he investigated the molecular genetics of myelodysplastic syndromes. He then joined the Mayo Clinic where he spent 5 years as a clinician-investigator in the Division of Hematology, the Associate Fellowship Program Director for Hematology, and an Associate Professor in the Mayo Clinic College of Medicine. Dr. Steensma joined Dana Farber Cancer Institute in 2009 as an attending hematologist-oncologist. He is also an attending physician in the Hematological Malignancies Service at Brigham And Women’s Hospital.

Dr. Steensma is a Fellow of the American College of Physicians. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the European Hematology Association, and the Alpha Omega Alpha medical honor society. He is also a member of the editorial board of 5 journals and has more than 150 publications in peer-reviewed journals. Dr. Steensma’s laboratory and clinical research has been funded by the National Cancer Institute and by several philanthropic groups. His primary clinical and research focus is myelodysplastic syndromes and he maintains an active interest in non-malignant hematology, especially disorders of red cells and therapy of cancer-associated anemia.

Peter E. Manley, MD

Director of Pediatric Neuro-Oncology Outcomes Clinic, Dana-Faber Cancer Institute
Senior Physician, Pediatrics, Dana-Faber Cancer Institute
Assistant Professor of Pediatrics, Harvard Medical School

Dr. Manley received his MD from Virginia Commonwealth University, Medical College in 1998. He completed residency training at Floating Hospital for Children at Tufts from 1998-2001, followed by a fellowship in Pediatric Hematology/Oncology at Hasbro Children’s Hospital in Providence, RI from 2001-2004. He then completed an additional fellowship in Pediatric Neuro-Oncology at Boston Children’s Hospital/Dana-Farber Cancer Institute from 2004-2005. Dr. Manley then joined Boston Children’s Hospital/Dana-Farber Cancer Institute, specializing in Late Effects of Pediatric Brain Tumors and Neuro-Oncology.

Dr. Manley serves as the Director of Pediatric Neuro-Oncology Outcomes Clinic at Dana-Faber Cancer Institute, as well as a physician at both the Brain Tumor Center and Cancer Survivorship Program. Dr. Manley is currently the Chair of The Consortium for New England Childhood Cancer Survivors. On a national level, he is a member of the Neurology Late Effects Task Force Survivorship and Outcomes Committee Task Force for the Children’s Oncology Group. He considered a leader in the Pediatric Neuro-Oncology community and is frequently invited to give lectures on the advancement in the care of pediatric brain tumor patients at various institutions.

Dr. Manley is involved in numerous research studies, with a particular focus the survivors of craniopharyngioma and outcomes of pediatric neuro-oncology treatments. He is also a peer reviewer for journals focusing on neuro-oncology and pediatric oncology and serves on the editorial board for the journal: Interdisciplinary Neurosurgery: Advanced Techniques and Case Management.

Peter A. Nigrovic, MD

Director, Center for Adults with Pediatric Rheumatic Illness (CAPRI), Brigham and Women’s Hospital
Director, Arthritis Biorepositories, Boston Children’s Hospital & Brigham and Women’s Hospital
Chair, Translational Research and Technology Committee, CARRA
Associate Professor of Medicine, Harvard Medical School

Dr. Nigrovic received his MD from Harvard University in 1995. He completed the Harvard Combined Residency Program In Medicine And Pediatrics in 1999 follow by fellowships in Pediatric Allergy/Rheumatology/Immunology at Brigham and Women’s Hospital and Boston Children’s Hospital in 2004. Dr. Nigrovic joined Brigham and Women’s Hospital, specializing in both pediatric and adult rheumatology. He is also affiliated with Boston Children’s Hospital. He sees both adult and children with arthritis, with a particular interest in systemic juvenile idiopathic arthritis and on the lifelong care of arthritis in children.

Dr. Nigrovic is the director of the Center for Adults with Pediatric Rheumatic Illness (CAPRI) at Brigham and Women’s Hospital. He also directs arthritis biorepositories at both Brigham and Women’s Hospital and Boston Children’s Hospital. His research focuses on understanding the mechanisms of inflammatory arthritis. Dr. Nigrovic serves as the chair for the Translational Research and Technology Committee of the US/Canadian pediatric rheumatology research group CARRA (the Childhood Arthritis and Rheumatology Research Alliance).

Dr. Nigrovic is an associate editor at Arthritis & Rheumatology. Dr. Nigrovic is an award-winning mentor for junior scientists and was founding co-chair of AMIGO, the American College of Rheumatology’s inter-institutional mentoring program in pediatric rheumatology. Dr. Nigrovic is an associate professor of medicine at Harvard Medical School and was named on Boston Magazine’s Top Doctor List in 2016.

Michael J. Birrer, MD, PhD

Director of Comprehensive Cancer Center, University of Alabama at Birmingham
Former Director of Gynecologic Oncology Research Program, Massachusetts General Hospital Cancer Center
Former Director of Gillette Center for Medical Gynecologic Oncology, Massachusetts General Hospital
Former Professor of Medicine, Harvard Medical School

Dr. Birrer received his MD and PhD from Albert Einstein College of Medicine in 1982. He completed residency training at Massachusetts General Hospital, followed by a fellowship in Medical Oncology at the National Cancer Institute (NCI).

Dr. Birrer then joined the faculty at the NCI in the Division of Cancer Treatment as an investigator in 1988. In 1991, Dr. Birrer was appointed as a senior investigator (with tenure) and established the molecular mechanism section in the Division of Cancer Prevention and Control. Dr. Birrer joined MGH in 2008 and was Director of both the Gynecologic Oncology Research Program and the Gillette Center for Medical Gynecologic Oncology.

Over the years, Dr. Birrer has held a number of positions including the Committee for the Protection of Human Subjects, Gynecologic Oncology Tumor Board, Extramural IRB, Clinical Oncology Fellowship Section Committee, Chair of the Gynecologic Oncology Working Group in the Division of Clinical Sciences and Deputy Branch Chief of the Cell and Cancer Biology Branch.

Dr. Birrer is recognized nationally and internationally as an expert in gynecologic oncology. He has published over 270 peer reviewed manuscripts and another 27 book chapters and review articles. He has served in leadership positions within the greater gynecologic oncology community. Currently, Dr. Birrer serves as the Director of Comprehensive Cancer Center at the University of Alabama at Birmingham.

Andrew X. Zhu, MD, PhD

Director of Liver Cancer Research, Massachusetts General Hospital
Attending Physician, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School

Dr. Andrew Zhu received his medical education at Beijing University and his PhD from Columbia University. He completed his residency training at Yale-New Haven Hospital in Connecticut, followed by an oncology fellowship at Memorial Sloan Kettering Cancer Center. Dr. Zhu serves as the Director of Liver Cancer Research at Massachusetts General Hospital.

Dr. Zhu is an internationally recognized expert in hepatocellular carcinoma and cholangiocarcinoma. His clinical and research interests have focused on developing innovative therapies for hepatobiliary cancers, identifying novel molecular markers and genetic mutations, and dissecting the molecular mechanisms of drug resistance to targeted therapy in hepatobiliary cancers.

Dr. Zhu serves on the Hepatobiliary Cancer Committee of the National Comprehensive Cancer Network (NCCN), the Grants Selection Committee of the American Society of Clinical Oncology (ASCO), the Hepatobiliary Cancer Task Force of The NCI Gastrointestinal Cancer Steering Committee (GISC), the American Joint Committee on Cancer (AJCC) Hepatobiliary Task Force, the Hepatocellular Carcinoma Practice Guidelines Committee of the American Association for the Study of Liver Diseases (AASLD), and the Clinical Advisory Board of the Cholangiocarcinoma Foundation.

Ramy Arnaout, MD, PhD

Director of the Arnaout Laboratory for Immunomics
Associate Director, Clinical Microbiology, Beth Israel Deaconess Medical Center
Staff Pathologist, Beth Israel Deaconess Medical Center
Assistant Professor of Pathology, Harvard Medical School
Faculty, Division of Clinical Informatics, Beth Israel Deaconess Medical Center
Faculty, Systems Biology PhD Program, Harvard Medical School

Dr. Arnaout received his MD from Harvard Medical School in 2003. He received his PhD Oxford University, where he was a British Marshall Scholar. Dr. Arnaout completed his residency at the Brigham & Women’s Hospital in Boston, where he served as chief resident in clinical pathology. He also held post-doctoral appointments at the Broad Institute for Genomics and the Program for Evolutionary Dynamics at Harvard University. Dr. Arnaout is a clinical pathologist and systems biologist at Beth Israel Deaconess Medical Center and Harvard Medical School. He currently serves as the Director of the Arnaout Laboratory for Immunomics and the Associate Director of Clinical Microbiology at Beth Israel Deaconess Medical Center.

Ravi Kavasary, MD

Medical Director, Clinical Performance and Development, Iora Health, Boston MA
Attending Physician, Hospitalist Medicine Unit, Brigham and Women’s Hospital
Associate Scientist, Division of Global Health Equity, Brigham and Women’s Hospital
Lecturer in Medicine, Harvard Medical School

Dr. Kavasery received his MD from Yale University School of Medicine in 2010. He completed his residency training in Internal Medicine and Primary Care at Brigham and Women’s Hospital. Dr. Kavasery joined Iora Health in 2013 as a Primary Care Physician. He then joined Brigham and Women’s Hospital in 2014 as an Attending Hospitalist Physician and an Associate Scientist in Division of Global Health Equity. In 2016, Dr. Kavasery became the Medical Director of Clinical Performance and Development at Iora Health where he leads a multidisciplinary team responsible for building and advancing Iora Health’s clinical care delivery model for scale. Dr. Kavasery also serves as a Lecturer in Medicine at Harvard Medical School.

Kamden Kopani, MD

Attending Ophthalmologist, Tufts Medical Center
Cornea Specialist, Tufts Medical Center
Assistant Professor of Ophthalmology, Tufts University School of Medicine

Dr. Kopani received his MD from Harvard Medical School in 2009. He then completed his residency at the Oregon Health and Science University in Portland, Oregon. Following this, Dr. Kopani completed a fellowship in Cornea External Disease, Tufts Medical Center/Ophthalmic Consultants of Boston. After completing his fellowship, Dr. Kopani joined the cornea service at New England Eye Center at Tufts Medical Center in 2014. Dr. Kopani is currently an attending Ophthalmologist and Cornea Specialist at Tufts Medical Center.

Allan Lapey, MD

Emeritus Director, MGH Cystic Fibrosis Center, Massachusetts General Hospital
Principal Investigator, MGH Cystic Fibrosis Therapeutic Development Center
Associate Clinical Professor of Pediatrics, Massachusetts General Hospital

Dr. Lapey received his MD from University of Rochester School of Medicine and Dentistry in 1966. He completed his residency at Boston Children’s Hospital and the National Institute for Arthritis and Metabolic Diseases in 1968 followed by a fellowship at Massachusetts General Hospital in 1972. Dr. Lapey then joined Massachusetts General Hospital where he specializes in Pediatric Pulmonology, Allergy, and Immunology. Dr. Lapey served as the Director of the MGH Cystic Fibrosis Center and is currently the Principal Investigator of the MGH Cystic Fibrosis Therapeutic Development Center.

Phillip Pearl, MD

Director of Epilepsy and Clinical Neurophysiology, Boston Children’s Hospital
William G. Lennox Chair, Harvard Medical School
Professor of Neurology, Harvard Medical School

Dr. Pearl received his MD from University of Maryland School of Medicine in 1984. He then completed a residency in Pediatrics followed by an additional residency in Neurology and Child Neurology at Baylor College of Medicine from 1984-1989. Dr. Pearl completed a fellowship in Clinical Neurophysiology at Boston Children’s Hospital and Beth Israel Hospital via Harvard Medical School from1989-1990. Dr. Pearl is the former chief of the neurology division at Children’s National Medical Center in Washington, D.C. and is a former professor of pediatrics, neurology and music at George Washington University.

In 2014, Dr. Pearl joined Boston Children’s Hospital at the Director of Epilepsy and Clinical Neurophysiology. He also currently serves as the William G. Lennox Chair and Professor of Neurology at Harvard Medical School. Since joining Boston Children’s Hospital, Dr. Pearl has started the Epilepsy Monitoring Unit, has reorganized the neurology division into clinical and academic programs, and has launched new programs such as ICU-EEG Monitoring and International Epilepsy.

Paul Monach, MD, PhD

Director of the Boston University Vasculitis Center
Associate Professor of Medicine, Boston University School of Medicine

Dr. Monach received his MD from the University of Chicago in 1999. He then completed two residencies at Brigham and Women’s Hospital in 2001 and 2005. Dr. Monach joined Boston Medical Center and, its medical school association, Boston University Medical Center as both a physician and researcher. Dr. Monach’s primary research is focused on clinical and translational research in vasculitis: biomarkers, genetics, and clinical trials.

Dr. Monach serves as the Director of the Boston University Vasculitis Center. He is also a principle investigator in the Vasculitis Clinical Research Consortium (VCRC). Dr. Monach sees patients with all forms of vasculitis, as well as general rheumatology patients. Dr. Monach is currently leading a study to look in vasculitis at genes that have been implicated in other autoimmune diseases such as rheumatoid arthritis, lupus, and Crohn’s disease, with grant support from the Arthritis Foundation.

Thomas Toth, MD

Director, Vincent In Vitro Fertilization Unit, Massachusetts General Hospital
Director, Reproductive Endocrinology & Infertility Fellowship Training Program, Massachusetts General Hospital
Associate Professor of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School

Dr. Toth received his MD from the University of Missouri – Kansas City School of Medicine in 1986. He then completed his residency at Brigham and Women’s Hospital followed by a fellowship in Reproductive Endocrinology and Infertility at the Jones Institute for Reproductive Medicine. Dr. Toth joined Massachusetts General Hospital in 1992 as a reproductive endocrinology and infertility specialist and associate professor at Harvard Medical School. Dr. Toth founded the Vincent In Vitro Fertilization Unit and the Reproductive Endocrinology & Infertility Fellowship Training Program at Massachusetts General Hospital. He currently serves as Director of both programs.

Dr. Toth received the 2002 UMKC School of Medicine Alumni Achievement Award, the 2013 UMKC School of Medicine E. Grey Dimond, M.D., Take Wing Award, and has been recognized by Boston Magazine as the top doctor for women in infertility.

Josna Adusumilli, MD

Attending Neurologist, Massachusetts General Hospital 
Sleep Expert, Massachusetts General Hospital
Instructor in Neurology, Harvard Medical School

Dr. Adusumilli received her MD from the University of Missouri – Kansas City School of Medicine. While completing her medical degree, she received the Sarah Morrison Student Research Award. She then completed a residency in neurology at the University of Arkansas for Medical Sciences, where she was selected to attend the Neurology Resident Scholars Program in Toronto, Canada. Dr. Adusumilli completed a fellowship in Sleep Medicine at Brigham and Women’s Hospital, where she received the Physician Scientist Training Award from the American Academy of Sleep Medicine. She also completed a fellowship in Clinical Neurophysiology at Beth Israel Deaconess Medical Center.

Dr. Adusumilli joined Massachusetts General Hospital’s department of Neurology, where she specializes in sleep medicine and neurophysiology. She is considered an expert in sleep medicine. She currently sees patients in the Division of Sleep Medicine lab at Massachusetts General Hospital and serves as an instructor in Neurology at Harvard Medical School.

Robert Graham, MD

Attending Physician, Critical Care Medicine, Boston Children’s Hospital
Associate Professor, Harvard Medical School

Dr. Graham received his MD from the David Geffen School of Medicine at University of California Los Angeles in 1996. He then completed a residency in pediatrics in the Boston Combined Residency Program in Pediatrics at Boston Children’s Hospital and Boston Medical Center, where he served as Chief Resident from 1999-2000. Dr. Graham completed his fellowship in pediatric critical care at Boston Children’s Hospital from 2000-2004. He then joined Boston Children’s Hospital in the department of Critical Care Medicine.

Dr. Graham is currently associated with various critical care programs at Boston Children’s Hospital including the Medical Surgical Intensive Care Unit (MSICU), Spinal Muscular Atrophy Program, Anesthesia Perioperative Extension (CAPE), and Home Ventilation Program. His primary research interests are in Critical Care, Special Health Care Needs and Technology Dependence, and Palliative Care. He also serves as an associate professor at Harvard Medical School.

Andrea Bullock, MD

Attending Physician, Hematology/Oncology, Beth Israel Deaconess Medical Center
Instructor of Medicine, Harvard Medical School

Dr. Bullock received her MD, with honors, from Washington University School of Medicine in St. Louis in 2004. She completed her residency in internal medicine followed by a fellowship in hematology/oncology at Beth Israel Deaconess Medical Center. Dr. Bullock then joined Beth Israel Deaconess Medical Center and currently serves as an attending physician in hematology/oncology.

Dr. Bullock specializes in the treatment of gastrointestinal malignancies including colorectal, gastric, neuroendocrine, and pancreaticobiliary. She serves as a member of the Developmental Therapeutics Program and Gastrointestinal Malignancies Program at the Dana Farber/Harvard Cancer Center. Dr. Bullock is an instructor in medicine at Harvard Medical School. She received a Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.

Manuel Hidalgo, MD, PhD

Chief, Hematology Oncology, Beth Israel Deaconess Medical Center
Director, Rosenberg Clinical Cancer Center, Beth Israel Deaconess Medical Center
Co-Director, Pancreatic Cancer Research Program, Beth Israel Deaconess Medical Center
Deputy Associate Director, Clinical Science, Executive Committee, Dana Farber/Harvard Cancer Center
Professor of Medicine, Harvard Medical School
Member, Center Scientific Council, Dana Farber/Harvard Cancer Center

Dr. Hidalgo received his MD from the University of Navarra in Madrid, Spain in 1992 and his PhD from the University Autonoma of Madrid in 1997. He completed a fellowship in anticancer drug development at the University of Texas Health Science Center in San Antonio. Dr. Hidalgo joined Johns Hopkins Unversity Kimmel Cancer Center as an attending cardiologist and associate professor in 2001 and became co-director of its newly created Gastrointestinal Cancer Program in 2003. Dr. Hidalgo has served as the Director of Oncology for the National Cancer Institute of Spain, Editorial Board of the Journal of Clinical Oncology and Clinical Cancer Research. He is the co-founder and Chairman of the international Pancreatic Cancer Research Team and is also a member of the NCI Developmental Therapeutics Study. He is a founder of the Pancreatic Cancer Research Team (PCRT), a private nonprofit cooperative group dedicated to rapid drug development in pancreatic cancer.

In 2015, Dr. Hidalgo joined Beth Israel Deaconess Medical Center (BIDMC) where he serves as the Director of the Leon V. & Marilyn L. Rosenberg Clinical Cancer Center and Chief of the Division of Hematology-Oncology. He is the Co-Director of the Pancreatic Cancer Research Program at BIDMC and the Deputy Associate Director of Clinical Science at the Dana Farber/Harvard Cancer Center. Dr. Hidalgo is a Professor of Medicine at Harvard Medical School. He also serves as the Director of the Clinical Research Program and Vice Director of Translational Research at the Spanish National Cancer Center.

Nazem Atassi, MD

Associate Director, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital
Founder and Co- Chair of the Upper Motor Neuron and the Imaging committees, Northeast ALS Consortium
Co-Chair of the Upper Motor Neuron Task Force, Northeast ALS Consortium
Assistant Professor of Neurology, Harvard Medical School

Dr. Atassi received his MD from Damascus University School of Medicine. He then completed his residency in neurology at Boston University Medical Center and Boston Medical Center followed by a fellowship in Neuromuscular Disorders and Clinical Trials at Massachusetts General Hospital in 2009. In 2010, Dr. Atassi received his Master’s of Medical Science degree from Harvard Medical School. Dr. Atassi then joined Massachusetts General Hospital in the department of neurology, specializing in the treatment of neuromuscular disorders and Amyotrophic Lateral Sclerosis (ALS). He currently serves as the Associate Director, Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital.

Dr. Atassi is the Founder and Co- Chair of the Upper Motor Neuron and the Imaging committees and the Co-Chair of the Upper Motor Neuron Task Force at the Northeast ALS Consortium. He is also an Assistant Professor of Neurology at Harvard Medical School. Dr. Atassi has been recognized for his expertise through several awards including the MIT 100K Life Science Award from Massachusetts Institute of Technology (MIT), the Anne B. Young Translational Neuroscience Fellowship, and NIH K23 Career Development Award. He is the Primary Investigator for several research projects focusing on Amyotrophic Lateral Sclerosis (ALS) clinical trials and neuroimaging. His research is funded by the National Institute of Health (NIH), ALS Association, ALS Finding a Cure, and Harvard NeuroDiscovery Center.

Thabele Leslie-Mazwi, MD

Attending Neurologist, Massachusetts General Hospital
Assistant Professor of Neurology, Harvard Medical School

Dr. Leslie-Mazwi received his MD, with honors, from University of Zimbabwe School of Medicine. He completed his residency in neurology at the Mayo Clinic followed by fellowships in Neurocritical Care and Neuroendovascular Care at Massachusetts General Hospital. Dr. Leslie-Mazwi joined Massachusetts General Hospital where he specializes in both Neuroendovascular and Neurocritical care, including stroke, atherosclerotic disease, arteriovenous malformations and intracranial aneurysms.

Dr. Leslie-Mazwi manages the MGH Neurocritical Care Service for several months of the year where he treats critically ill patients suffering from diseases of the brain and spine. He has various appointments on important committees focusing on quality improvement, carotid disease, endovascular stroke care and hereditary hemorrhagic telangiectasia. He is also a reviewer for several cerebrovascular journals, as well as a key member of the Society of Neurointerventional Surgery. Dr. Leslie-Mazwi is an Assistant Professor of Neurology at Harvard Medical School.

Daniel Solomon, MD

Attending Physician, Massachusetts General Hospital
Instructor of Medicine, Harvard Medical School

Dr. Solomon received his MD from Yale University School of Medicine in 2010. He completed a combined internship and residency in Internal Medicine at Brigham and Women’s Hospital. He then completed a fellowship in Infectious Disease at Massachusetts General Hospital. Dr. Solomon joined Mount Auburn Hospital as a Primary Care/Internal Medicine Specialist with a specialization in Infectious Disease.

Dr. Solomon sees a variety of patients in the Primary Care Center at Mount Auburn Hospital. He has a particular interest in home based programs, community engagement, and social determinants of health.

Contact Us

We are here for you! For more information about our services or company, please send us a note.

Contact Us